NASA Ames Research Center takes on CytoProbe's acoustic intracranial pressure (ICP) device:
This article was originally published in Clinica
Executive Summary
CytoProbe's (US) noninvasive, acoustic device for diagnosis of intracranial pressure (ICP) has started human clinical trials at the NASA Ames Research Center. The trials will be performed by the Center's Life Sciences Division under Alan Hargens. The device obviates the need for surgical procedures to measure ICP, says CytoProbe; current measurement techniques comprise drilling a hole in the skull and inserting a catheter with a pressure transducer.
You may also be interested in...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.